<DOC>
	<DOCNO>NCT01811680</DOCNO>
	<brief_summary>To conduct feasibility clinical trial test novel patient sense automate treadmill device devise local engineer subacute hemiplegic stroke patient gait rehabilitation . This phase 1 feasibility safety trial device 10 chronic stroke patient hemiparetic gait dysfunction conduct period 2 month . Research protocol standardize outcome measure use .</brief_summary>
	<brief_title>An Exploratory Clinical Study Variable Speed Sensing Treadmill System ( VASST ) Hemiparetic Gait Rehabilitation</brief_title>
	<detailed_description>To conduct feasibility clinical trial test novel patient sense automate treadmill device devise local engineer subacute hemiplegic stroke patient gait rehabilitation . This device incorporate patient automate variable speed feedback , increase safety feature patient support harness visual feedback provide ambulatory gait monitoring data . Methodology : 10 stable subacute hemiparetic stroke subject undergo supervise treadmill train use device target improve gait speed walk independence . Outcomes measure 4 time point pre post training use clinical scale temporal-spatial gait measurement . Importance research medicine : This study test possibility patient initiate control close loop sense feedback system provide increase intensity , reduce risk gait destabilisation fall risk associate current fix treadmill training . Potential benefit new device : Ability train self select variable speed include fast speed , improve hemiplegic leg swing initiation stride length , less assistance require physiotherapist reduce fall risk due overhead safety harness treadmill sense increased patient confidence . Possibility ambulatory gait speed force load treadmill training . Potential risk : Minor risk fall minimise safety harness supervision physiotherapist . Anticipated risk relate repetitive treadmill training regard cardiovascular musculoskeletal side effect mitigate strict patient inclusion exclusion criterion .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Gait Disorders , Neurologic</mesh_term>
	<mesh_term>Methamphetamine</mesh_term>
	<criteria>1 . First ever stroke ( ischaemic haemorrhagic ) confirm Computed Tomography Magnetic Resonance image 2 . Aged 21 80 year 3 . Stroke duration &gt; 3 month outpatient phase ( subacute chronic stroke ) 4 . Able walk overground selfselected speed &gt; 0.2m/s without walk aid low limb orthoses least 150 meter contact guard supervision . 5 . Functional ambulation category ( FAC &gt; /= 2 ) ( Holden et al 1994 ) 1 . Cardiovascular condition uncontrolled hypertension/hypotension , angina pectoris , recent myocardial infarction , congestive cardiac failure , know echocardiographic ejection fraction &lt; 40 % within 3 month stroke , chronic arrhythmia ( e.g . atrial fibrillation ) within 3 month study screening , pacemaker , uncontrolled Diabetes Mellitus . 2 . End stage illness ( advanced malignancy ) , pregnancy end stage renal failure life expectancy &lt; 6 month . 3 . Aphasia ( inability obey 2 step command ) , communication disorder preclude understanding instruction , cognitive impairment , dementia , untreated depression psychiatric disorder . 4 . Active low limb arthritis , Pain ( Visual Analogue Scale ) &gt; 5/10 , fix orthopaedic deformity low limb would compromise safe ambulation treadmill . 5 . Moderate severe low limb spasticity spasm ( Modified Ashworth Scale &gt; 2 ) 6 . Active trunk skin condition , know abdominal aortic aneurysm , anticoagulation warfarin preclude safe fit gait harness</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Stroke</keyword>
	<keyword>Hemiplegia</keyword>
	<keyword>Variable automate treadmill treadmill</keyword>
</DOC>